Brief: Adocia Announces Positive Topline Results Of Phase 1B Study For M1Pram

Adocia SA

15/09/2020 06:36

Sept 15 (Reuters) - ADOCIA SA  ADOC.PA :
    * ADOCIA ANNOUNCES POSITIVE TOPLINE RESULTS OF PHASE 1B
STUDY FOR
M1PRAM IN PEOPLE WITH TYPE 1 DIABETES
    * PRIMARY ENDPOINT MET: REDUCTION OF 69% OF POST-MEAL
GLYCEMIC
EXCURSIONS (DELTA AUC-PG) OVER FOUR HOURS VERSUS.
NOVOLOG(®)(P=0.03)
    * BOTH TREATMENTS WERE WELL TOLERATED, AND NO SERIOUS
ADVERSE
EVENTS WERE REPORTED DURING 24 DAYS OF TREATMENT

Source text for Eikon:  ID:nBw9t9blla 
Further company coverage:  ADOC.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))